Ceftiofur
Sold as Spectramast dc, Excede, Cefenil rtu, Cevaxel rtu, Excenel, Excenel fluid, Excede for swine
(6R,7R)-7-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(furan-2-carbonylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 6328657.
Background
Registration
- Applicants
- 3
- Registrations
- 7
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Zoetis South Africa (Pty) Ltd1 of 5 cancelled | Spectramast dc, Excede, Excenel, Excenel fluid, Excede for swine | 200 mg/ml | 06/20, 1-Oct, 89/1, A03/11, A05/05 | S4 | None |
| Biotech Laboratories (Pty) LtdCancelled | Cefenil rtu | Not stated | 12/05 | S4 | None |
| Ceva Animal Health (Pty) Ltd | Cevaxel rtu | 50 mg | 8-Dec | S4 | PI |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Spectramast dc EACH 10,0 ml SUSPENSION CONTAINS: CEFTIOFUR HYDROCHLORIDE 500,0 mg | Not listed | 06/2006/16.1/20 | Registered | S4 | None |
| Excede 200 mg/ml EACH 1,0 ml SUSPENSION CONTAINS CEFTIOFUR 200,0 mg | 200 mg/ml | 1-Oct10/21.1/01 | Registered | S4 | None |
| Cefenil rtu EACH 1,0 ml SOLUTION CONTAINS CEFTIOFUR SODIUM EQUIVALENT TO CEFTIOFUR 50,0 mg | Not listed | 12/0512/17.1.1.2/05 | Cancelled | S4 | None |
| Cevaxel rtu EACH 1,0 ml SOLUTION CONTAINS CEFTIOFUR HYDROCHLORIDE EQUIVALENT TO CEFTIOFUR 50,0 mg | 50 mgInjectable suspension | 8-Dec12/17.1.1.2/08Approved 12 October 2021 | Registered | S4 | PI |
| Excenel EACH 1,0 ml SOLUTION CONTAINS CEFTIOFUR SODIUM EQUIVALENT TO CEFTIOFUR 50,0 mg | Not listed | 89/189/21.1/1 | Registered | S4 | None |
| Excenel fluid EACH 1,0 ml SUSPENSION CONTAINS CEFTIOFUR HYDROCHLORIDE EQUIVALENT TO CEFTIOFUR 50,0 mg | Not listed | A03/11A03/21.1/11 | Registered | S4 | None |
| Excede for swine EACH 1,0 ml SUSPENSION CONTAINS CEFTIOFUR 100,0 mg | Not listed | A05/05A05/17.1.1.2/05 | Cancelled | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Ceftiofur hydrochloride
S4: Ceftiofur
Consolidated Schedules 06 July 2026, line 5749
Pharmacological class: Nasal decongestants. (class 16.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.